BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2188748)

  • 21. Beneficial effects of a 5-lipoxygenase inhibitor in endotoxic shock in the rat.
    Matera G; Cook JA; Hennigar RA; Tempel GE; Wise WC; Oglesby TD; Halushka PV
    J Pharmacol Exp Ther; 1988 Oct; 247(1):363-71. PubMed ID: 3171981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-649,923: an antagonist of cardiac and vascular leukotriene D4 receptors.
    Sirén AL; Eimerl J; Feuerstein G
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):210-7. PubMed ID: 2468948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukotriene antagonist FPL 57231 prevents the acute pulmonary effects of Escherichia coli endotoxin in cats.
    Pacitti N; Bryson SE; McKechnie K; Rodger IW; Parratt JR
    Circ Shock; 1987; 21(2):155-68. PubMed ID: 3549040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of EFA deficiency with dietary triglycerides or phospholipids in a murine model of extrahepatic cholestasis.
    Werner A; Havinga R; Kuipers F; Verkade HJ
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G822-32. PubMed ID: 14670824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Terbutaline increases survival after endotoxin shock. A comparative study of methyl prednisolone, isoprenaline and terbutaline in rats.
    Sigurdsson GH; Christenson JT
    Microcirc Endothelium Lymphatics; 1986-1987; 3(3-4):231-40. PubMed ID: 3431524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood volume changes in endotoxin shock.
    Hubbard JD; Pugh JL; Berlin SA; Janssen HF
    Circ Shock; 1985; 17(4):339-48. PubMed ID: 4092347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thromboxane and prostacyclin production during septic shock.
    Butler RR; Wise WC; Halushka PV; Cook JA
    Adv Shock Res; 1982; 7():133-45. PubMed ID: 6753528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD; Mikulaschek AW
    Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of alpha adrenergic blockade on arachidonic acid metabolism and shock sequelae in endotoxemia.
    Armstrong J; Tempel GE; Cook JA; Wise WC; Halushka PV
    Circ Shock; 1986; 20(2):151-9. PubMed ID: 3096591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of angiotensin I and glucagon in canine endotoxin shock: effect of converting enzyme inhibitor and prior immunization.
    Manson NH; Hess ML
    Circ Shock; 1984; 12(3):177-89. PubMed ID: 6325034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of LTB4 receptor antagonists in endotoxic shock in the rat.
    Li EJ; Cook JA; Wise WC; Jackson WT; Halushka PV
    Circ Shock; 1991 Aug; 34(4):385-92. PubMed ID: 1663429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of recombinant human superoxide dismutase on increased lung vascular permeability and respiratory disorder in endotoxemic rats.
    Schneider J; Friderichs E; Heintze K; Flohé L
    Circ Shock; 1990 Feb; 30(2):97-106. PubMed ID: 2178795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole body plasma extravasation in saline and Haemaccel loaded rats: effects of endotoxemia.
    van Lambalgen AA; van den Bos GC; Thijs LG
    Int J Microcirc Clin Exp; 1990 Aug; 9(3):303-18. PubMed ID: 2394551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha 2 macroglobulin of the rat, an acute phase protein, mitigates the early course of endotoxin shock.
    van Vugt H; van Gool J; de Ridder L
    Br J Exp Pathol; 1986 Jun; 67(3):313-9. PubMed ID: 2424486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung injury caused by cobra venom factor is reduced in rats raised on an essential fatty acid-deficient diet.
    Morganroth ML; Schoeneich SO; Till GO; Pickett W; Ward PA
    Am J Physiol; 1989 Oct; 257(4 Pt 2):H1192-9. PubMed ID: 2801979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endotoxin increases pulmonary vascular protein permeability in the dog.
    Welsh CH; Dauber IM; Weil JV
    J Appl Physiol (1985); 1986 Oct; 61(4):1395-402. PubMed ID: 3536835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective blood-tumor barrier disruption by leukotrienes.
    Chio CC; Baba T; Black KL
    J Neurosurg; 1992 Sep; 77(3):407-10. PubMed ID: 1506887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of essential fatty acid deficiency and of carbon tetrachloride-induced liver cirrhosis on oral carcinogenesis in the rat.
    Lekholm U; Wallenius K
    Odontol Revy; 1976; 27(3):165-80. PubMed ID: 824589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic hemodynamic effects of leukotrienes C4 and D4 in the rat.
    Pfeffer MA; Pfeffer JM; Lewis RA; Braunwald E; Corey EJ; Austen KF
    Am J Physiol; 1983 Apr; 244(4):H628-33. PubMed ID: 6837761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endotoxemia alters splanchnic capacitance.
    Ujhelyi MR; Miller AW; Raibon S; Corley J; Robinson VJ; Sims JJ; Tonnessen T; Burke G; Ilebekk A; Rutlen DL
    Shock; 2000 Jul; 14(1):68-72. PubMed ID: 10909896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.